Industry
Medical - Pharmaceuticals
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Loading...
Open
5.24
Mkt cap
241M
Volume
458K
High
5.61
P/E Ratio
-8.69
52-wk high
12.88
Low
5.21
Div yield
N/A
52-wk low
3.99
Portfolio Pulse from Benzinga Insights
June 10, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
June 07, 2024 | 4:44 pm
Portfolio Pulse from Benzinga Newsdesk
June 05, 2024 | 9:36 am
Portfolio Pulse from Benzinga Newsdesk
May 31, 2024 | 6:31 pm
Portfolio Pulse from Benzinga Newsdesk
May 30, 2024 | 7:25 pm
Portfolio Pulse from Benzinga Newsdesk
May 29, 2024 | 12:06 pm
Portfolio Pulse from Benzinga Newsdesk
May 21, 2024 | 3:45 pm
Portfolio Pulse from Benzinga Newsdesk
May 10, 2024 | 12:42 pm
Portfolio Pulse from Benzinga Newsdesk
May 09, 2024 | 3:00 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.